Suppr超能文献

结直肠癌同步肝转移切除术时机。

Timing of resection for synchronous liver metastases from colorectal cancer.

机构信息

Department of Surgery, Hirakata Hospital, Kansai Medical University, 2-3-1 Shinmachi, Hirakata, Osaka, Japan.

出版信息

Dig Dis Sci. 2010 Nov;55(11):3262-70. doi: 10.1007/s10620-009-1124-6. Epub 2010 Jan 29.

Abstract

BACKGROUND

This study aimed to compare the surgical outcome and long-term survival between simultaneous and delayed resection of liver metastases from colorectal cancer (LM), and to identify the factors influencing hepatic disease-free survival in patients with synchronous LM.

METHODS

Seventy-four patients with LM were divided into two groups, i.e., 32 patients who underwent hepatectomy at the time of colorectal surgery (simultaneous group) and 42 patients who underwent delayed liver resection (delayed group).

RESULTS

The hepatic disease-free survival rates of patients from the delayed group with either ≥ 3 or <3 liver metastases were significantly better than that of the simultaneous group. Multivariate analysis showed that simultaneous resection was one of three independent prognostic indicators with an influence on hepatic disease-free survival. In 13 of the 42 (31%) patients from the delayed group, new metastatic lesions were found in the same and/or different segments after re-evaluation during the interval between operations. These patients had a higher incidence of poorly differentiated or mucinous adenocarcinoma, shorter interval between procedures, and larger tumors than patients without tumor progression.

CONCLUSIONS

Tumor progression could be recognized and occult metastases were detected during the interval between operations. Delayed resection of synchronous LM may be useful to reduce the risk of rapid recurrence in the remnant liver. Patients with poorly differentiated or mucinous adenocarcinoma and those with larger tumors who undergo delayed liver resection should receive neoadjuvant chemotherapy during the interval between operations.

摘要

背景

本研究旨在比较结直肠癌肝转移(LM)同期与延期切除的手术效果和长期生存,明确影响同步 LM 患者肝无瘤生存的因素。

方法

74 例 LM 患者分为同期组(32 例,在结直肠手术时行肝切除术)和延期组(42 例,延期行肝切除术)。

结果

延期组中≥3 枚和<3 枚肝转移患者的肝无瘤生存率明显优于同期组。多因素分析显示同期切除是影响肝无瘤生存的 3 个独立预后因素之一。在延期组的 42 例患者中,13 例(31%)在两次手术的间隔期重新评估时发现同一或不同肝段出现新的转移灶。这些患者的肿瘤分化差或黏液腺癌比例高、两次手术间隔时间短、肿瘤较大,与无肿瘤进展的患者相比,前者具有更高的肿瘤进展发生率。

结论

在两次手术的间隔期可发现肿瘤进展和隐匿性转移。延期切除同步 LM 可能有助于降低残肝快速复发的风险。对接受延期肝切除术的分化差或黏液腺癌患者以及肿瘤较大的患者,在两次手术的间隔期应给予新辅助化疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验